Cargando…
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
Testicular germ cell tumors (TGCTs) are a cancer pharmacology success story with a majority of patients cured even in the highly advanced and metastatic setting. Successful treatment of TGCTs is primarily due to the exquisite responsiveness of this solid tumor to cisplatin-based therapy. However, a...
Autores principales: | Singh, Ratnakar, Fazal, Zeeshan, Freemantle, Sarah J., Spinella, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752046/ https://www.ncbi.nlm.nih.gov/pubmed/31538140 http://dx.doi.org/10.20517/cdr.2019.19 |
Ejemplares similares
-
Between a Rock and a Hard Place: An Epigenetic-Centric View of Testicular Germ Cell Tumors
por: Singh, Ratnakar, et al.
Publicado: (2021) -
Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors
por: Singh, Ratnakar, et al.
Publicado: (2019) -
Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
por: Bakardjieva-Mihaylova, Violeta, et al.
Publicado: (2019) -
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020) -
Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines
por: Roška, Jan, et al.
Publicado: (2020)